Sponsor or institution
Clinical trials and research at L2 Diagnostics, LLC
As of November 12, 2026, Find a Trial lists 12 NIH-funded research projects at this institution, with $4.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12NIH research projects
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Vaccine to block malaria spread by targeting mosquito metabolism
A vaccine aimed at blocking malaria transmission by mosquitoes, helping communities where malaria is common.
-
Point-of-care test for Babesia microti
A new rapid test to detect Babesia microti infections right at the patient’s side or when screening donated blood.
-
PfAg: a peptide-based malaria vaccine targeting CSP and AgTRIO
A small, peptide-based malaria vaccine candidate aims to train the immune system to fight malaria by targeting specific parasite and mosquito proteins.
-
A new topical therapy (L2ASOCLE) for treating cutaneous lupus erythematosus (CLE)
A first‑in‑class topical treatment called L2ASOCLE targets a key molecule involved in CLE to reduce skin inflammation and damage.
-
Finding new ways to diagnose malaria.
This study is looking for new ways to test for malaria more accurately and quickly, which could help patients get the right treatment sooner and feel better faster.
-
A vaccine to prevent Chikungunya fever
This project is working to create a new vaccine that uses a mosquito protein to protect people from Chikungunya fever.
-
A new treatment for Lyme arthritis
This research is exploring a new type of medicine to help people who continue to experience joint pain and other symptoms after being treated for Lyme disease.
-
A new malaria vaccine delivered through easy-to-use microneedle patches
This study is working on a new malaria vaccine that uses a protein from mosquito saliva and is delivered through easy-to-use microneedle patches, making it less painful and more convenient, especially for people in areas with limited resources.
-
A vaccine to prevent tick-borne diseases
This study is testing a new mRNA vaccine designed to help protect people from diseases like Lyme disease that are spread by tick bites, by training your immune system to fight off the ticks' saliva.
-
Investigating a mosquito protein as a potential vaccine against Chikungunya
This study is working on a new vaccine to help protect people from Chikungunya, a virus spread by mosquitoes, by using a special protein from mosquito saliva that helps the virus spread, so they can better understand how to keep you safe from getting sick.
-
A new treatment for Lyme arthritis using a specific protein inhibitor
This study is exploring a new treatment for Lyme arthritis that might help people who haven't found relief with regular antibiotics, using a special protein that could help fight the bacteria and ease their symptoms.
-
A new vaccine targeting Zika virus using mosquito saliva proteins
This study is testing a new vaccine for the Zika virus that uses a protein from mosquito saliva to help boost the body's defense against the virus, and it's aimed at anyone interested in better protection from mosquito-borne illnesses.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.